Dantrolene sodium in neuroleptic malignant syndrome and hepatic impairment.
Velamoor
V R
VR
D000328:Adult; D003620:Dantrolene / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000150:complications*; D008111:Liver Function Tests; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy*; D010259:Paranoid Disorders / Q000188:drug therapy*; D014268:Trifluoperazine / Q000008:administration & dosage / Q000009:adverse effects*
D014268:Trifluoperazine; D003620:Dantrolene